EdgarLookup

KROGER CO — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that KROGER CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.7%
Profit Margin
Net income ÷ revenue
2%
Return on Assets
Net income ÷ assets
7.43x
Debt-to-Equity
Total liabilities ÷ equity
+0.4%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $147.64B Mar 31, 2026
FY2025 Feb 1, 2025 $147.12B Mar 31, 2026
FY2025 Feb 3, 2024 $150.04B Mar 31, 2026
FY2025 Jan 28, 2023 $148.26B Apr 1, 2025
FY2024 Jan 29, 2022 $137.89B Apr 2, 2024
FY2020 Jan 30, 2021 $30.74B Mar 30, 2021
FY2020 Nov 7, 2020 $29.72B Mar 30, 2021
FY2020 Aug 15, 2020 $30.49B Mar 30, 2021
FY2020 May 23, 2020 $41.55B Mar 30, 2021
FY2020 Feb 1, 2020 $28.89B Mar 30, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $1.02B Mar 31, 2026
FY2025 Feb 1, 2025 $2.67B Mar 31, 2026
FY2025 Feb 3, 2024 $2.16B Mar 31, 2026
FY2025 Jan 28, 2023 $2.24B Apr 1, 2025
FY2024 Jan 29, 2022 $1.66B Apr 2, 2024
FY2020 Jan 30, 2021 ($77.00M) Mar 30, 2021
FY2020 Nov 7, 2020 $631.00M Mar 30, 2021
FY2020 Aug 15, 2020 $819.00M Mar 30, 2021
FY2020 May 23, 2020 $1.21B Mar 30, 2021
FY2020 Feb 1, 2020 $327.00M Mar 30, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $1.89B Mar 31, 2026
FY2025 Feb 1, 2025 $3.85B Mar 31, 2026
FY2025 Feb 3, 2024 $3.10B Mar 31, 2026
FY2025 Jan 28, 2023 $4.13B Apr 1, 2025
FY2024 Jan 29, 2022 $3.48B Apr 2, 2024
FY2020 Jan 30, 2021 ($158.00M) Mar 30, 2021
FY2020 Nov 7, 2020 $792.00M Mar 30, 2021
FY2020 Aug 15, 2020 $820.00M Mar 30, 2021
FY2020 May 23, 2020 $1.33B Mar 30, 2021
FY2020 Feb 1, 2020 $537.00M Mar 30, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $7.31B Mar 31, 2026
FY2025 Feb 1, 2025 $5.79B Mar 31, 2026
FY2025 Feb 3, 2024 $6.79B Mar 31, 2026
FY2025 Jan 28, 2023 $4.50B Apr 1, 2025
FY2024 Jan 29, 2022 $6.19B Apr 2, 2024
FY2022 Jan 30, 2021 $6.82B Mar 28, 2023
FY2021 Feb 1, 2020 $4.66B Mar 29, 2022
FY2020 Feb 2, 2019 $4.16B Mar 30, 2021
FY2019 Feb 3, 2018 $3.41B Apr 1, 2020
FY2018 Jan 28, 2017 $4.27B Apr 2, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $49.95B Mar 31, 2026
FY2025 Feb 1, 2025 $52.62B Mar 31, 2026
FY2025 Feb 3, 2024 $50.51B Apr 1, 2025
FY2024 Jan 28, 2023 $49.62B Apr 2, 2024
FY2022 Jan 29, 2022 $49.09B Mar 28, 2023
FY2021 Jan 30, 2021 $48.66B Mar 29, 2022
FY2020 Feb 1, 2020 $45.26B Mar 30, 2021
FY2019 Feb 2, 2019 $38.12B Apr 1, 2020
FY2018 Feb 3, 2018 $37.20B Apr 2, 2019
FY2017 Jan 28, 2017 $36.51B Apr 18, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $44.02B Mar 31, 2026
FY2025 Feb 1, 2025 $44.34B Mar 31, 2026
FY2025 Feb 3, 2024 $38.90B Apr 1, 2025
FY2024 Jan 28, 2023 $39.61B Apr 2, 2024
FY2022 Jan 29, 2022 $39.66B Mar 28, 2023
FY2021 Jan 30, 2021 $39.11B Mar 29, 2022
FY2020 Feb 1, 2020 $36.68B Mar 30, 2021
FY2019 Feb 2, 2019 $30.28B Apr 1, 2020
FY2018 Feb 3, 2018 $30.29B Apr 2, 2019
FY2017 Jan 28, 2017 $29.80B Apr 18, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $5.93B Mar 31, 2026
FY2025 Feb 1, 2025 $8.29B Mar 31, 2026
FY2025 Feb 3, 2024 $11.62B Apr 1, 2025
FY2024 Jan 28, 2023 $10.04B Apr 2, 2024
FY2022 Jan 29, 2022 $9.45B Mar 28, 2023
FY2021 Jan 30, 2021 $9.58B Mar 29, 2022
FY2020 Feb 1, 2020 $8.60B Mar 30, 2021
FY2019 Feb 2, 2019 $7.89B Apr 1, 2020
FY2018 Feb 3, 2018 $6.93B Apr 2, 2019
FY2017 Jan 28, 2017 $6.70B Apr 18, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $2.60B Mar 31, 2026
FY2025 Feb 1, 2025 $2.67B Mar 31, 2026
FY2025 Feb 3, 2024 $2.92B Mar 31, 2026
FY2025 Jan 28, 2023 $2.92B Apr 1, 2025
FY2024 Jan 29, 2022 $3.08B Apr 2, 2024
FY2022 Jan 30, 2021 $3.08B Mar 28, 2023
FY2020 Feb 1, 2020 $3.08B Mar 30, 2021
FY2020 Feb 2, 2019 $3.09B Mar 30, 2021
FY2019 Feb 3, 2018 $2.93B Apr 1, 2020
FY2018 Jan 28, 2017 $3.03B Apr 2, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $28.85B Mar 31, 2026
FY2025 Feb 1, 2025 $28.72B Mar 31, 2026
FY2025 Feb 3, 2024 $26.95B Apr 1, 2025
FY2024 Jan 28, 2023 $25.60B Apr 2, 2024
FY2022 Jan 29, 2022 $24.07B Mar 28, 2023
FY2021 Jan 30, 2021 $23.02B Mar 29, 2022
FY2020 Feb 1, 2020 $20.98B Mar 30, 2021
FY2019 Feb 2, 2019 $19.68B Apr 1, 2020
FY2018 Feb 3, 2018 $17.01B Apr 2, 2019
FY2017 Jan 28, 2017 $15.54B Apr 18, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $3.33B Mar 31, 2026
FY2025 Feb 1, 2025 $3.96B Mar 31, 2026
FY2025 Feb 3, 2024 $1.88B Apr 1, 2025
FY2024 Jan 28, 2023 $1.02B Apr 2, 2024
FY2022 Jan 29, 2022 $1.82B Mar 28, 2023
FY2021 Jan 30, 2021 $1.69B Mar 29, 2022
FY2020 Feb 1, 2020 $399.00M Mar 30, 2021
FY2019 Feb 2, 2019 $429.00M Apr 1, 2020
FY2018 Feb 3, 2018 $347.00M Apr 2, 2019
FY2017 Jan 28, 2017 $322.00M Apr 18, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $15.88B Mar 31, 2026
FY2025 Feb 1, 2025 $15.91B Mar 31, 2026
FY2025 Feb 3, 2024 $10.19B Apr 1, 2025
FY2024 Jan 28, 2023 $11.29B Apr 2, 2024
FY2022 Jan 29, 2022 $11.75B Mar 28, 2023
FY2021 Jan 30, 2021 $12.41B Mar 29, 2022
FY2020 Feb 1, 2020 $13.26B Mar 30, 2021
FY2019 Feb 2, 2019 $14.35B Apr 1, 2020
FY2018 Feb 3, 2018 $14.79B Apr 2, 2019
FY2017 Jan 28, 2017 $13.32B Apr 18, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 1 Mar 31, 2026
FY2025 Feb 1, 2025 3 Mar 31, 2026
FY2025 Feb 3, 2024 2 Mar 31, 2026
FY2025 Jan 28, 2023 3 Apr 1, 2025
FY2024 Jan 29, 2022 2 Apr 2, 2024
FY2020 Jan 30, 2021 0 Mar 30, 2021
FY2020 Nov 7, 2020 0 Mar 30, 2021
FY2020 Aug 15, 2020 1 Mar 30, 2021
FY2020 May 23, 2020 1 Mar 30, 2021
FY2020 Feb 1, 2020 0 Mar 30, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 1 Mar 31, 2026
FY2025 Feb 1, 2025 3 Mar 31, 2026
FY2025 Feb 3, 2024 2 Mar 31, 2026
FY2025 Jan 28, 2023 3 Apr 1, 2025
FY2024 Jan 29, 2022 2 Apr 2, 2024
FY2020 Jan 30, 2021 0 Mar 30, 2021
FY2020 Nov 7, 2020 0 Mar 30, 2021
FY2020 Aug 15, 2020 1 Mar 30, 2021
FY2020 May 23, 2020 1 Mar 30, 2021
FY2020 Feb 1, 2020 0 Mar 30, 2021

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $885.00M Mar 31, 2026
FY2025 Feb 1, 2025 $883.00M Mar 31, 2026
FY2025 Feb 3, 2024 $796.00M Mar 31, 2026
FY2025 Jan 28, 2023 $682.00M Apr 1, 2025
FY2024 Jan 29, 2022 $589.00M Apr 2, 2024
FY2022 Jan 30, 2021 $534.00M Mar 28, 2023
FY2021 Feb 1, 2020 $486.00M Mar 29, 2022
FY2020 Feb 2, 2019 $437.00M Mar 30, 2021
FY2019 Feb 3, 2018 $443.00M Apr 1, 2020
FY2018 Jan 28, 2017 $429.00M Apr 2, 2019